Detection of Biological Threat Agents by Real-Time PCR: Comparison of Assay Performance on the R.A.P.I.D., the Lightcycler, And the Smart Cycler Platforms (Technical Briefs) Detection of Biological Threat Agents by Real-Time PCR: Comparison of Assay Performance on the R.A.P.I.D., the Lightcycler, And the Smart Cycler Platforms (Technical Briefs)

Detection of Biological Threat Agents by Real-Time PCR: Comparison of Assay Performance on the R.A.P.I.D., the Lightcycler, And the Smart Cycler Platforms (Technical Briefs‪)‬

Clinical Chemistry 2006, Jan, 52, 1

    • € 2,99
    • € 2,99

Publisher Description

Because disease-causing microorganisms can be used as aerobiological weapons, accurate and timely identification of these agents is necessary (1-4). Important agents include Bacillus anthracis (anthrax), Brucella species (brucellosis), Clostridium botulinum (botulism), Coxiella burnetii (Q fever), Francisella tularensis (tularemia), Staphylococcus aureus, and Yersinia pestis (plague) (5). Real-time PCR can rapidly detect the presence of nucleic acid markers with small reaction volumes and rapid cycling. Assay chemistry is increasingly important in this identification process because the choices and concentrations of enzymes, buffers, salts, primers, and probes affect assay detection limits (6-12). Real-time PCR assays for detecting biological warfare agents have been developed on the R.A.P.I.D.[R] (Idaho Technology, Inc.), LightCycler[R] (Roche), and Smart Cycler[R] (Cepheid) platforms and are compatible with various fluorescence-based methods such as TagMan[R] (13, 14), hybridization probes (15, 16), molecular beacons (17-19), Scorpion primers (20), LUXE primers (21-24), AEGIS primers (25-27), and SimpleProbes[R] (IT Biochem). We investigated whether these assays produce comparable sensitivity and specificity on these rapid cycling instruments.

GENRE
Science & Nature
RELEASED
2006
1 January
LANGUAGE
EN
English
LENGTH
14
Pages
PUBLISHER
American Association for Clinical Chemistry, Inc.
SIZE
214.9
KB

More Books by Clinical Chemistry

Detection of Antinuclear Antibodies by Solid-Phase Immunoassays and Immunofluorescence Analysis (Clinical Immunology) Detection of Antinuclear Antibodies by Solid-Phase Immunoassays and Immunofluorescence Analysis (Clinical Immunology)
2004
Clinical Evaluation of Toxi * Prep[Tm]: A Semiautomated Solid-Phase Extraction System for Screening of Drugs in Urine (Drug Monitoring and Toxicology) Clinical Evaluation of Toxi * Prep[Tm]: A Semiautomated Solid-Phase Extraction System for Screening of Drugs in Urine (Drug Monitoring and Toxicology)
1997
Telomerase Detection in Body Fluids. Telomerase Detection in Body Fluids.
2002
Oral Dehydroepiandrosterone Supplementation can Increase the Testosterone/Epitestosterone Ratio (Technical Briefs) Oral Dehydroepiandrosterone Supplementation can Increase the Testosterone/Epitestosterone Ratio (Technical Briefs)
1999
Biological Variation of Tumor Markers and Its Application in the Detection of Disease Progression in Patients with Non-Small Cell Lung Cancer (Technical Briefs) Biological Variation of Tumor Markers and Its Application in the Detection of Disease Progression in Patients with Non-Small Cell Lung Cancer (Technical Briefs)
2005
Detection of Circulating Prostate-Specific Antigen-Secreting Cells in Prostate Cancer Patients (Technical Briefs) Detection of Circulating Prostate-Specific Antigen-Secreting Cells in Prostate Cancer Patients (Technical Briefs)
2005